Lv51
898 积分 2024-10-09 加入
Continuous glucose monitoring-based metrics and the duration of hypoglycaemia events with once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-naive type 2 diabetes: an exploratory analysis of ONWARDS 1
3天前
已完结
Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial
18天前
已完结
Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial
18天前
已完结
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis
18天前
已完结
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
18天前
已完结
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
18天前
已完结
Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approaches
18天前
已关闭
Premixed Insulin Analogues for the Treatment of Diabetes Mellitus
25天前
已完结
Science of premix insulin: where have we reached?
1个月前
已完结
Insulin degludec/insulin aspart produces a dose‐proportional glucose‐lowering effect in subjects with type 1 diabetes mellitus
1个月前
已完结
皖公网安备34019202002308
